Prof Ivo Mueller
Honorary (Professorial Fellow)
Department of Medical Biology (WEHI)
596 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Rapid detection of G6PD deficiency SNPs using a novel amplicon-based minion sequencing assay
DOI: 10.1038/s41598-025-31822-42026
Journal article
Predicting risk of Plasmodium vivax microscopy-detected episodes using serological markers in patients with Plasmodium falciparum malaria: a multi-country diagnostic performance evaluation.
DOI: 10.1093/infdis/jiag1642026
Journal article
Autoantibodies Against Type I Interferons are a Prominent Feature in SARS-CoV-2 Fatal Disease and Hospitalization
DOI: 10.1093/infdis/jiaf5142026
Journal article
A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria
DOI: 10.1016/j.immuni.2026.02.0032026
Journal article
Antibody responses following COVID-19 vaccination and breakthrough infections in naïve and convalescent individuals suggest imprinting to the ancestral strain of SARS-CoV-2
DOI: 10.1128/mbio.03221-252023
Research grants (ARC, NHMRC, MRFF)
Accelerating to Zero: Targeting Roadblocks to Achieve Malaria Elimination
2014
Journal article
Reappraisal of known malaria resistance loci in a large multicenter study
DOI: 10.1038/ng.3107
RECENT SCHOLARLY WORKS
2026
Journal article
Correction: Population genetics of Plasmodium vivax with transmission decline and rebound in two endemic areas of Papua New Guinea (Frontiers in Genetics, (2026), 16, (1621920), 10.3389/fgene.2025.1621920)
DOI: 10.3389/fgene.2026.18053492026
Journal article
Population genetics of Plasmodium vivax with transmission decline and rebound in two endemic areas of Papua New Guinea
DOI: 10.3389/fgene.2025.16219202025
Journal article
Applying novel Plasmodium Vivax serological exposure markers to quantify residual malaria transmission in the Philippines through repeated health facility surveys: the SMaRT study protocol
DOI: 10.1186/s12879-025-10934-22025
Journal article
Quantification of the IgG antibody response half-life for hybrid immunity to SARS-CoV-2
DOI: 10.1186/s12916-025-04490-42025
Journal article
Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis
DOI: 10.1186/s12936-025-05642-w